alias:: Insufficiency fracture, fragility fracture
ICD-11_Code:: FB70.0 (Pathological fracture due to osteoporosis), FB70.1 (Pathological fracture due to neoplasm), FB70.2 (Other specified pathological fractures)
tags:: #Disease, #[[Degenerative Disease]], #Orthopedics

- #definition {{c1 A definite Pathological fracture refers to a bone fracture that occurs at the site of a pre-existing local abnormality or generalized skeletal disease, where the bone is weakened to the point that it breaks under minimal or no trauma}} #ortho-prof-card
- ## Etiology
  background-color:: blue
	- ### Causative Agents
	  #ortho-prof-card #ortho-prof-written
		- Genetic/ Congenital
			- Osteogenesis imperfecta ("brittle bone disease")
			- Paget's disease of bone
		- Neoplastic
			- Metastatic cancer (breast, lung, prostate, kidney, thryoid)
			- Primary bone tumors (osteosarcoma, multiple myeloma, Ewing's sarcoma)
		- Non-neoplastic Bone Lesions
			- Bone cysts (unicameral, aneurysmal)
			- Fibrous dysplasia
			- Giant cell tumor
		- Infections
			- Osteomyelitis (chronic, bacterial/fungal)
		- Metabolic
			- Osteoporosis (most common)
			- Osteomalacia/Vitamin D deficiency
			- Hyperparathyroidism (renal/secondary)
	- ### Risk Factors
		- Age : Older adults (osteoporosis, metastases) vs. young (benign tumors)
		- Cancer History : Prior malignancy ↑ risk of metastatic bone disease.
		- Chronic Steroid Use : Glucocorticoids -> osteoporosis
		- Immobility : Disuse osteoporosis
		- Chronic Infections : TB osteomyelitis, diabetic osteoarthropathy
		- Radiation Therapy : ↑ fracture risk in irradiated bones.
- ## Epidemiology
  background-color:: blue
	- ### Incidence
	- ### Prevalence
		- ### Demographics
	- ### Geographic Distribution
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
	- ### Affected Systems/Organs
- ## Clinical Features
  background-color:: blue
	- ### Clinical Presentation
		- **Pain** (often precedes fracture in malignancy/Paget’s).
		- **Low-energy mechanism** (e.g., fall from standing height).
		- **Pathognomonic signs:**
			- Fracture at unusual site (e.g., femoral shaft without trauma).
			- Multiple fractures in different healing stages (suggests systemic disease).
	- ### Common Sites #ortho-prof-card
		- Vertebral Column (most common site overall, especially in osteoporosis and metastatic cancer)
		- Femur
			- Femoral Neck : osteoporosis, metastases
			- Shaft : Paget's disease
		- Humerus
			- Proximal Humerus : Metastases, Multiple Myeloma
			- Diaphysis : Lytic lesions
		- Pelvis
			- Acetabulum/pelvis : metastasis
			- Sacrum : osteoporosis
		- Ribs : Frequent in multiple myeloma and metastatic carcinoma
		- Tibia & Fibula : Benign lesions
		- Clavicle & Scapula : Rare
		- ### **Key Patterns by Etiology**
		  
		  | **Disease** | **Typical Fracture Sites** |
		  | ---- | ---- | ---- |
		  | **Osteoporosis** | Vertebrae, hip, distal radius (Colles’) |
		  | **Metastatic Cancer** | Spine, femur, humerus, pelvis |
		  | **Multiple Myeloma** | Vertebrae, ribs, long bones |
		  | **Paget’s Disease** | Femur (lateral bowing), tibia, pelvis |
		  | **Osteogenesis Imperfecta** | Multiple long bones, vertebrae |
- ## Diagnosis
  background-color:: blue
	- **Imaging:**
		- **X-ray:** Lytic/sclerotic lesions, cortical thinning.
		- **MRI/CT:** Assess soft tissue involvement (e.g., spinal cord compression).
		- **Bone scan:** Screen for metastases.
	- **Biopsy:** Mandatory if malignancy suspected.
	- **Labs:** Calcium, ALP, serum electrophoresis (for myeloma).
- ## Management and Treatment
  background-color:: blue
	- ### Principle of Management of Pathological Fracture #ortho-prof-written
		- **Multidisciplinary approach** (orthopedic surgeon, oncologist, endocrinologist, radiologist).
		- Diagnosis & Evaluation
			- History & Examination : Assess for underlying malignancy, osteopororis, infection, or metabolic bone disease
			- Imaging
				- X-rays (initial screening, may show lytic/sclerotic lesions)
				- CT/MRI (for detailed bone and soft tissue assessment)
				- Bone scan (DEXA for osteoporosis, PET/CT for metastasis)
			- Biopsy : If malignancy is suspected (to confirm pathology)
			- Lab Tests : CBC, ESR/CRP, calcium, vitamin-D, alkaline phosphatase, tumor markers
		- Stabilization of Fracture
			- Bracing/Splinting/Casting (if non-dispalced, low-stress)
			- Pain control : NSaids, opiods, bisphosphonates (for bone pain in metastases)
			- Radiotherapy : If fracture is due to metastatic cancer (reduces pain and progression)
			- Surgical management (if indicated)
		- Treatment of Underlying Pathology
		- Rehabilitation & Prevention
- ## Prognosis
  background-color:: blue
	- Depends on primary disease (e.g., poor with advanced metastases, good with osteoporosis).
- ## Prevention
  background-color:: blue
	- Bisphosphonates reduce risk in osteoporosis; prophylactic fixation for impending fractures.
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
	- ### Support Groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
	- ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue
- #SN Short Note #ortho-prof-written